No results for ‘’
Trident Lifeline Ltd
NSE: BSE: 543616
₹402.60
(9.22%)
Sat, 26 Sept 2026, 07:05 pm
Market Cap (in Cr)439.85
PE Ratio22.49
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KTrident Lifeline Cashflow
| Particulars | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Deprecation and amortization | -1.15M | -1.44M | -2.03M | -3.65M | -9.70M | -54.92M |
| Accumulated depreciation, total | -2.59M | -3.26M | -4.04M | -5.58M | -11.00M | -114.01M |
| Cash from operating activities | -13.50M | 10.81M | -3.40M | -187.11M | 30.77M | -116.05M |
| Funds from operations | -9.51M | 9.98M | 33.28M | 64.05M | 72.80M | 145.66M |
| Net income (cash flow) | -7.96M | 6.32M | 39.48M | 60.15M | 63.44M | 117.48M |
| Depreciation & amortization (cash flow) | 1.15M | 1.44M | 2.03M | 3.65M | 9.70M | 54.92M |
| Depreciation/depletion | 528.00K | 668.00K | 782.00K | 1.53M | 5.43M | 46.48M |
| Amortization | 626.00K | 769.00K | 1.24M | 2.11M | 4.27M | 8.44M |
| Deferred taxes (cash flow) | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-cash items | 92.00K | 0 | 1.42M | -5.42M | -23.85M | -45.42M |
| Changes in working capital | -3.99M | 836.00K | -36.68M | -251.16M | -42.03M | -261.70M |
| Cash from investing activities | -780.00K | -5.58M | -4.45M | -104.42M | -218.20M | -164.47M |
| Capital expenditures | -780.00K | -5.58M | -4.55M | -69.24M | -178.91M | -111.00M |
| Capital expenditures - fixed assets | -780.00K | -1.86M | -4.55M | -69.24M | -178.91M | -111.00M |
| Capital expenditures - other assets | — | -3.72M | -4.38M | — | — | — |
| Cash from financing activities | 15.11M | -5.54M | 9.28M | 427.49M | 116.13M | 237.46M |
| Free cash flow | -14.28M | 8.96M | -7.96M | -256.35M | -148.14M | -227.04M |